Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers February 25, 2017
Pharmacy Choice - News - Front Page Healthcare News - February 25, 2017

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

2/25/17 - 6 key trends affecting healthcare real estate in 2017 [Gulf Marketing Review (Middle East)]
Republicans have made efforts to repeal the ACA since its enactment, but Congress has not yet acted in 2017 to make significant changes to the law. Republicans have circulated multiple plans to replace the law, and Republican leadership has indicated that a replacement plan should reverse the expansion of Medicaid, strengthen Medicare, and give tax
2/25/17 - Auris Medical Receives FDA Fast Track Designation for AM-111 in Acute Sensorineural Hearing Loss [Sudan Tribune]
-Zug, Switzerland, Feb. 24, 2017- Auris Medical Holding AG, a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced that the US Food and Drug Administration has granted Fast Track designation for AM-111 in the treatment of acute sensorineural hearing loss.
2/25/17 - Baebies Receives FDA de novo Clearance for First Lysosomal Storage Disease Newborn Screening Platform, SEEKER
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week- Baebies, a company focused on advancing newborn screening and pediatric testing, announced it has received de novo clearance from the U.S. Food and Drug Administration for SEEKER. "Although these LSDs have FDA approved therapies, this is a significant milestone for the LSD
2/25/17 - Certificate of Need, licensing requirements could be cut in Iowa [The Gazette, Cedar Rapids, Iowa]
"In his Condition of the State address, Gov. Branstad asked the legislature to take a comprehensive review of all of our state's boards and commissions to address unnecessary barriers that prevent competition and raise costs on Iowans," said Ben Hammes, Branstad's spokesman, in an email. "Thirty-three percent of Iowa's workforce is licensed the
2/25/17 - Dr. Reddy`s` Miryalaguda plant issued with Form483 after US FDA audit [Syrian Arab News Agency]
Dr Reddys Laboratories has been issued with a Form483 after an inspection at its active pharmaceutical ingredient plant in Miryalaguda in Telangana, India. The site was one of several Dr Reddys facilities criticized in a US FDA warning letter published in 2015.. In addition, the FDA said Dr. Reddys had failed to prevent unauthorized access to quali
2/25/17 - Farenthold briefs supporters on town halls, 'Obamacare' and intel leaks [Corpus Christi Caller-Times, Texas]
Feb. 24 The Republican-controlled Congress is set to "easily" repeal the financial backing of the Affordable Care Act next month, U.S. Rep. Blake Farenthold said at a Tea Party meeting Thursday night in Corpus Christi. The fourth term congressman said the financial components of President Barack Obama's landmark healthcare reform will be deconstr
2/25/17 - FDA Approves EMFLAZA? deflazacort Tablets and Oral Suspension for the Treatment of Duchenne Muscular Dystrophy in Patients 5 Years and Older
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week The FDA granted EMFLAZA priority review, which is reserved for investigational medicines that may offer major advances in treatment over existing options. "We are pleased to learn that the FDA has approved EMFLAZA," said Pat Furlong, founding President and CEO of Parent Proj
2/25/17 - FDA Issues Final Rule for New Animal Drugs for Use in Animal Feed
WASHINGTON, Feb. 25 The Food and Drug Administration published the following rule in the Federal Register for approval of New Animal Drug applications and withdrawal of approval of New Animal Drug Applications:. Where applicable, FDA is also withdrawing approval of those parts of the NADAs that pertain to use of these antimicrobial drugs for prod
2/25/17 - FDA Issues Rule for Withdrawal of Approval of New Animal Drug Application
WASHINGTON, Feb. 25 The Food and Drug Administration published the following rule in the Federal Register for withdrawal of Approval of a New Animal Drug Application:. Sujaya Dessai, Center for Veterinary Medicine, Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-402-5761, sujaya.dessai@fda.hhs.gov. Putney, Inc., One Monu
2/25/17 - Findings from General Hospital Broadens Understanding of Aspartic Acid Endopeptidases (The Impact of Renin-Angiotensin System Blockade on Renal...
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Research findings on Enzymes and Coenzymes- Aspartic Acid Endopeptidases are discussed in a new report. According to news reporting out of Jeju, South Korea, by NewsRx editors, research stated, "Renin-angiotensin-system blockade is thought to slow renal progression in patient
2/25/17 - Global Dialysis Market: Industry Analysis & Outlook 2017-2021 - Demographic Factors Contribute to the Growth of Dialysis Market - Research and...
Global Dialysis Market: Industry Analysis& Outlook 2017-2021- Demographic Factors Contribute to the Growth of Dialysis Market- Research and Markets. By a News Reporter-Staff News Editor at Investment Weekly News Research and Markets has announced the addition of the "Global Dialysis Market: Industry Analysis& Outlook" report to their offering.
2/25/17 - Global Weight Loss and Obesity Management Market Forecast to 2024 New Report by Data Bridge Market Research
Global Weight Loss and Obesity Management Market, by Fitness Equipment (Cardiovascular Training Equipment, Strength Training Equipment, Body Composition Analyzers, Fitness Monitoring Equipment), by Surgical Equipment (Minimally Invasive Surgical Equipment, Non-Invasive Surgical Equipment), by Dietary Supplements, by Services, by Geography Indus
2/25/17 - High Price Device: Race to Innovate Medical Devices Fuels More Product Recalls
By a News Reporter-Staff News Editor at Journal of Transportation- The rapid pace of innovation in medical devices resulted in an unfortunate side effect of increasing medical device recalls in the second half of 2016, according to the July- Dec. 2016 Recall Industry Spotlight report released by Stericycle ExpertSOLUTIONS. The biannual Industry S
2/25/17 - Idera Pharmaceuticals Presents Update from Ongoing Phase 1 Dose Escalation Clinical Trial of Intratumoral IMO-2125 in Combination with Ipilimumab in Metastatic Melanoma Patients Refractory to Anti-PD-1 Treatment at the 2017 ASCO-SITC Clinical Immuno-
-Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and rare diseases, today is reporting additional data from the dose-escalation phase of its ongoing Phase 1/ 2 clinical trial of intratumoral IMO-2125, an agonist of TLR9 in combination with ipilimumab
2/25/17 - Intellipharmaceutics Announces FDA Approval for 500 mg and 750 mg Generic Glucophage XR [T-break Tech (Middle East)]
Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs announced that the Company today received final approval from the U.S. Food and Drug Administration for the Company`s abbreviated new drug...
2/25/17 - Maquet Expands Patent Infringement Lawsuit Against Saphena Medical and Dr. Chin, Adds Claims for False Advertising and Correction of Patent...
Maquet Expands Patent Infringement Lawsuit Against Saphena Medical and Dr. Chin, Adds Claims for False Advertising and Correction of Patent Inventorship. By a News Reporter-Staff News Editor at Marketing Weekly News Maquet Cardiovascular, LLC, a worldwide leader in endoscopic vessel harvesting medical devices, filed an amended complaint against S
2/25/17 - Mattress Headquarters Opens New Mattress Store in Lake Charles, LA.
Mattress Headquarters, a new mattress& adjustable bed company in Lake Charles, LA opens its doors in Lake Charles, LA 70601. Mattress Headquarters offers mattresses, adjustable beds, power lift chairs, pillows, sheets& more. Donny Reed of Lake Charles, LA& Robert Green of Nederland, TX partner up to bring the Lake Area a new& unique mattress stor
2/25/17 - MedeAnalytics Receives 2017 Certification from NCQA for HEDIS Certified MeasuresSM
The certified HEDIS measure module leverages MedeAnalytics' investment in Apache SparkTM technology that provides increased performance gains with validated calculations in minutes. "Quality of care will continue to be a primary focus for healthcare, and as one of the earliest recipients of the NCQA certification, MedeAnalytics continues to.
2/25/17 - PAVmed Inc. Announces Closing of Financing
By a News Reporter-Staff News Editor at Investment Weekly News PAVmed Inc., a highly differentiated, multi-product medical device company, announced the closing of a $1.5 million financing. Lishan Aklog, Chairman and CEO of PAVmed, stated, "The strong investor interest in our company has been extremely gratifying. In addition, PAVmed expects to f
2/25/17 - Perrigo Confirms Patent Challenge For Generic Version Of Onexton Gel
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Perrigo Company plc announced that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration for clindamycin, benzoyl peroxide topical gel, the generic version of Onexton gel. Perrigo has notified Valeant Pharmaceuticals North America LLC
2/25/17 - Recombinant Drugs to 2020: Pace of Market Growth is Encouraging Suppliers to View Competitors in New Ways - Research and Markets
By a News Reporter-Staff News Editor at Investment Weekly News Research and Markets has announced the addition of the "Recombinant Drugs to 2020" report to their offering. This report examines FDA and EMA-approved biological drugs and their position and potential in a dozen major disease segments- markets with important implications for drug deve
2/25/17 - Sidra Achieves International Accreditation for Adopting Advanced Information Technology in Patient Care [Qatar News Agency]
The accreditation was achieved for using electronic medical records and other supporting technologies to enhance the quality of care provided to patients and families at the Sidra Outpatient Clinic, It said in a press statement Saturday. It puts the Sidra Outpatient Clinic in the same exclusive league as some of the top technologically advanced hos
2/25/17 - State uncertain onhealth funding
President Donald Trump and a Republican majority in Congress say they will repeal the Affordable Care Act and replace it in part with a Medicaid block grant plan even conservative Virginia lawmakers fear would punish the state. Congress also must decide by the end of September whether to reauthorize the children's health insurance program that pays
2/25/17 - Supply Of 2 Mobile X-ray Units With C-arm With Flat Panel [TendersInfo (India)]
Tenders are invited for Supply of 2 mobile X-ray units with C-arm with flat panel. Short description: The subject of the tender is the supply 2 pcs new, unused and nerepasovanho mobile X-ray C-arm with flat detector and the implementation of the warranty and post service. This contract is divided into lots: no.
2/25/17 - Two Clovis shareholders accuse cancer drug maker of violating FDA rules [Daily Camera, Boulder, Colo.]
Feb. 25 Two shareholders of Clovis Oncology are accusing the Boulder company of regulatory violations during clinical trials for its failed lung cancer drug rocilentinib,. Clovis disclosed the most recent allegations in a 10- K filed Thursday with the Securities and Exchange Commission, calling them "unfounded." The 10- K filing also reported tha
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415